author-photo

Kaspar Rufibach

University of Zurich
Hoffmann-La Roche

167

Papers

4327

Citations

Citation Trend

Filter By

Papers (167) Sort By

Journal Conference Others

Estimands for overall survival in clinical trials with treatment switching in oncology.

2021 Pharmaceutical Statistics
Show All
- Source
- Cite
- Save
Citations (0)
Estimands in hematologic oncology trials

2021 Pharmaceutical Statistics
Show All
- Source
- Cite
- Save
Citations (0)
Principal stratum strategy: Potential role in drug development.

2021 Pharmaceutical Statistics
Show All
- Source
- Cite
- Save
Citations (3)
Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation.

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Letter to the editor: On identification of the principal stratum effect in patients who would comply if treated

2021 Statistics in Biopharmaceutical Research
Show All
- Source
- Cite
- Save
Citations (1)
Comment on “Biostatistical considerations when using RWD and RWE in clinical studies for regulatory purposes: A landscape assessment”

2021 Statistics in Biopharmaceutical Research
Show All
- Source
- Cite
- Save
Citations (0)
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials

2021 The American Statistician
Show All
- Source
- Cite
- Save
Citations (1)
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.

2021 Trials
Show All
- Source
- Cite
- Save
Citations (0)
Conditional Power and Friends: The Why and How of (Un)planned, Unblinded Sample Size Recalculations in Confirmatory Trials.

2020 arXiv: Applications
Show All
- Source
- Cite
- Save
Citations (1)
Comparison of efficacy and safety with obinutuzumab plus chemotherapy versus rituximab plus chemotherapy in patients with previously untreated follicular lymphoma: Updated results from the phase III Gallium Study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)